Financials
- Market Capitalization 408.96 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2914 | AQST Aquestive Therapeutics, Inc. - Common Stock | 3.98 USD | -1.49% | -7.87% | -5.24% | -1.97% | 499.29 M USD | ||
| 3056 | KMDA Kamada Ltd. - Ordinary Shares | 7.17 USD | -1.38% | -1.78% | -3.24% | -5.53% | 413.61 M USD | ||
| 3078 | CGC Canopy Growth Corporation - Common Shares | 0.97 USD | +1.04% | +1.04% | -2.02% | -12.61% | 409.49 M USD | ||
| 3116 | EBS Emergent BioSolutions Inc. Common Stock | 7.53 USD | +0.27% | -7.72% | -9.28% | -29.76% | 388.52 M USD |
Frequently asked questions about Evolus, Inc. - Common Stock
What is the Evolus, Inc. - Common Stock stock price today?
The current price of Evolus, Inc. - Common Stock (EOLS) is 6.21. Over the past 24 hours, the stock has changed by -0.96%. Follow the EOLS chart for real-time price dynamics.
What is the stock ticker of Evolus, Inc. - Common Stock?
Evolus, Inc. - Common Stock trades under the ticker EOLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Evolus, Inc. - Common Stock stock going up?
EOLS has changed by -12.04% over the last week, -8.00% over the last month, and -33.15% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Evolus, Inc. - Common Stock net income for the last quarter?
Evolus, Inc. - Common Stock reported net income of -10.67 M for the last quarter. The previous quarter showed 130 K, which means net income changed by -8310.77%.
How many employees does Evolus, Inc. - Common Stock have?
As of the latest available data, Evolus, Inc. - Common Stock has 350 employees. Workforce size can provide additional context about the company's scale and operations.
What is Evolus, Inc. - Common Stock EBITDA?
Evolus, Inc. - Common Stock EBITDA is 19.74 M, and its EBITDA margin is 26.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Evolus, Inc. - Common Stock stock?
You can buy Evolus, Inc. - Common Stock (EOLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Evolus, Inc. - Common Stock stock?
Investing in Evolus, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EOLS chart and related analysis on metatrader.com as part of your research.